It all unfolds this summer.
Job creation. Medicinal properties.
Economic concerns. Health risks. Production quality.
This is where to find real facts and straight answers to all your questions concerning cannabis production in Canada. Over the next three months, we will share evidence-based information and resources on this site and through a series of monthly newsletters that explore health and wellness, economic impact, and consumer safety.
More than 130,000 Canadians use medical marijuana every year.
Marijuana production is expected to generate $22.6 billion annually.
Over $1 billion is spent annually to enforce cannabis possession laws.
Over the next three months, we will be sharing some evidence-based information with you about cannabis as it relates to health and wellness, the economy and consumer safety.
We want to hear from you.
We want to provide evidence and information to help answer your most urgent questions about this historic decision on cannabis in Canada. Take our survey and share your questions below.
Vote for what matters most to you.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Québec that will have over 1.5 million square feet of production space when completed. MYM is also a partner in a 1.2 million square-foot production project (the Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).